{"id":"581","presentation":"15P - Influence of PIK3CA mutations on breast cancer proliferation, lymphocyte infiltration and clinical outcome: Pooled analysis of 484 patients from three prospective multicentre GBG trials <small>(ID 581)<\/small>","session":"Poster lunch <small>(ID 46)<\/small>","filename":"19-04-24 influence of PIK3CA mutation (GBG trials) P. Jank.pdf","speaker":"Paul Jank<small> (Berlin, Germany)<\/small>","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/breast2019\/persons\/photos\/1189.jpg","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-presentations\/breast2019\/581\/jpg\/19-04-24influenceofpik3camutation(gbgtrials)p.jank\/thumbnails\/0.png","pdf":"\/file_access\/get_file\/E5960\/session_token\/13ded0519ef65ae6cb7d9d307cf353af","what":"pdf","code":"","priority":["html5","pdf","jpg","thumbnail"]}
[speaker]
[presentation]
[session]